20 Jun 2023
IP bolsters Company’s already dominant and broad position with respect to exosome therapeutics
Acquisition is in line with long-term strategy to improve exosome-mediated delivery to enable novel gene therapies and gene editors
OXFORD, United Kingdom, June 20, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, has purchased Codiak Biosciences engEx-AAV™ technology platform,... Read more